Theranostic Guided Riboflavin/UV-A Corneal Cross-linking
Clinical trial NCT05457647 · COMPLETED
Trial details
- NCT number
- NCT05457647
- Sponsor
- Regensight
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-27
- Primary completion
- 2024-01-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.